Markulan, L. and Makarevych, L. (2022) “Pembrolizumab as an immunotherapy drug in the treatment of a patient with recurrent (unresectable) cancer of the lower lip”, General Surgery, (2), pp. 75–82. doi: 10.30978/GS-2022-2-75.